405 related articles for article (PubMed ID: 31144314)
1. The potential role of exosomes derived from ovarian cancer cells for diagnostic and therapeutic approaches.
Yang C; Kim HS; Song G; Lim W
J Cell Physiol; 2019 Dec; 234(12):21493-21503. PubMed ID: 31144314
[TBL] [Abstract][Full Text] [Related]
2. Advances in Exosomal microRNAs and Proteins in Ovarian Cancer Diagnosis, Prognosis, and Treatment.
Qin T; Chen F; Zhu J; Ding Y; Zhang Q
Curr Mol Med; 2023; 23(6):509-520. PubMed ID: 35770407
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints.
Fanale D; Corsini LR; Bono M; Randazzo U; Barraco N; Brando C; Cancelliere D; Contino S; Giurintano A; Magrin L; Pedone E; Perez A; Piraino P; Pivetti A; Giovanni ED; Russo TDB; Prestifilippo O; Gennusa V; Pantuso G; Russo A; Bazan V
Crit Rev Oncol Hematol; 2024 Jan; 193():104220. PubMed ID: 38036154
[TBL] [Abstract][Full Text] [Related]
4. Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment.
Sun Z; Yang S; Zhou Q; Wang G; Song J; Li Z; Zhang Z; Xu J; Xia K; Chang Y; Liu J; Yuan W
Mol Cancer; 2018 Apr; 17(1):82. PubMed ID: 29678180
[TBL] [Abstract][Full Text] [Related]
5. microRNAs as biomarkers of ovarian cancer.
Zhang H; Lu B
Expert Rev Anticancer Ther; 2020 May; 20(5):373-385. PubMed ID: 32326768
[No Abstract] [Full Text] [Related]
6. Exosome-derived miRNAs and ovarian carcinoma progression.
Vaksman O; Tropé C; Davidson B; Reich R
Carcinogenesis; 2014 Sep; 35(9):2113-20. PubMed ID: 24925027
[TBL] [Abstract][Full Text] [Related]
7. The emerging roles and therapeutic potential of exosomes in epithelial ovarian cancer.
Li X; Wang X
Mol Cancer; 2017 May; 16(1):92. PubMed ID: 28506269
[TBL] [Abstract][Full Text] [Related]
8. Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.
Kanlikilicer P; Bayraktar R; Denizli M; Rashed MH; Ivan C; Aslan B; Mitra R; Karagoz K; Bayraktar E; Zhang X; Rodriguez-Aguayo C; El-Arabey AA; Kahraman N; Baydogan S; Ozkayar O; Gatza ML; Ozpolat B; Calin GA; Sood AK; Lopez-Berestein G
EBioMedicine; 2018 Dec; 38():100-112. PubMed ID: 30487062
[TBL] [Abstract][Full Text] [Related]
9. Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer.
Su YY; Sun L; Guo ZR; Li JC; Bai TT; Cai XX; Li WH; Zhu YF
J Ovarian Res; 2019 Jan; 12(1):6. PubMed ID: 30670062
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies.
Cheng L; Wu S; Zhang K; Qing Y; Xu T
J Ovarian Res; 2017 Nov; 10(1):73. PubMed ID: 29100532
[TBL] [Abstract][Full Text] [Related]
11. Exosomal lncRNAs and cancer: connecting the missing links.
Naderi-Meshkin H; Lai X; Amirkhah R; Vera J; Rasko JEJ; Schmitz U
Bioinformatics; 2019 Jan; 35(2):352-360. PubMed ID: 30649349
[TBL] [Abstract][Full Text] [Related]
12. The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications.
Ingenito F; Roscigno G; Affinito A; Nuzzo S; Scognamiglio I; Quintavalle C; Condorelli G
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546654
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer exosomes initiate global long non-coding RNA changes in mesenchymal stem cells.
Wang S; Li X; Zhu R; Han Q; Zhao RC
Int J Oncol; 2016 Feb; 48(2):681-9. PubMed ID: 26648258
[TBL] [Abstract][Full Text] [Related]
14. Exosomes-microRNAs interacted with gastric cancer and its microenvironment: a mini literature review.
Deng Z; Wu J; Xu S; Chen F; Zhang Z; Jin A; Wang J
Biomark Med; 2020 Feb; 14(2):141-150. PubMed ID: 32064893
[TBL] [Abstract][Full Text] [Related]
15. Exosomes and exosomal RNAs in breast cancer: A status update.
Lakshmi S; Hughes TA; Priya S
Eur J Cancer; 2021 Feb; 144():252-268. PubMed ID: 33373870
[TBL] [Abstract][Full Text] [Related]
16. Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer.
Maeda K; Sasaki H; Ueda S; Miyamoto S; Terada S; Konishi H; Kogata Y; Ashihara K; Fujiwara S; Tanaka Y; Tanaka T; Hayashi M; Ito Y; Kondo Y; Ochiya T; Ohmichi M
J Ovarian Res; 2020 Apr; 13(1):47. PubMed ID: 32336272
[TBL] [Abstract][Full Text] [Related]
17. Mimicking the tumor microenvironment: Fibroblasts reduce miR-29b expression and increase the motility of ovarian cancer cells in a co-culture model.
Medeiros M; Ribeiro AO; Lupi LA; Romualdo GR; Pinhal D; Chuffa LGA; Delella FK
Biochem Biophys Res Commun; 2019 Aug; 516(1):96-101. PubMed ID: 31200958
[TBL] [Abstract][Full Text] [Related]
18. The Role and Applications of Exosomes in Gynecological Cancer: A Review.
Wang KH; Ding DC
Cell Transplant; 2023; 32():9636897231195240. PubMed ID: 37632354
[TBL] [Abstract][Full Text] [Related]
19. LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway.
Wang A; Jin C; Li H; Qin Q; Li L
Int J Biol Macromol; 2018 Dec; 120(Pt B):1705-1713. PubMed ID: 30268751
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic, prognostic and therapeutic potential of circulating microRNAs in ovarian cancer.
Aboutalebi H; Bahrami A; Soleimani A; Saeedi N; Rahmani F; Khazaei M; Fiuji H; Shafiee M; Ferns GA; Avan A; Hassanian SM
Int J Biochem Cell Biol; 2020 Jul; 124():105765. PubMed ID: 32428568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
